ESG

REE Automotive and BorgWarner's Cascadia Motion partner to create a revolutionary 'off-the-shelf' electric drive unit, accelerating the EV transition.

Greenwich LifeSciences execs extend their stock lock-up to 6 years, signaling massive confidence in their breast cancer drug showing an 80% recurrence drop.

A $10.5M investment gives Enduring Wealth Capital near-majority control of Cango, accelerating its pivot to AI and raising questions about its future.

Adlai Nortye licenses its promising pan-RAS cancer inhibitor to ASK Pharm for Greater China in a deal valued at up to $230 million.

From coal-heavy to fully green, ACEN has completed a landmark transition. Inside the strategy that made it an Asia-Pacific renewable energy leader.

High turnout and a peaceful vote mark CAR's election, but President Touadéra's quest for a third term raises questions about the nation's democratic future.

With a strong debut on the Hong Kong Stock Exchange, USAS Building System highlights growing investor faith in prefabricated industrial construction.

Diamyd Medical's pivotal Phase 3 trial gets a nine-month acceleration, raising hopes for a new precision therapy that preserves insulin production.

A major order for advanced semiconductor equipment will fuel a European firm's expansion, powering next-gen AI data centers and LiDAR systems.

As pharma moves beyond small molecules, a new integrated platform helps developers navigate the challenges of PROTACs, peptides, and antibody drugs.

Croatian firm Orqa is building a global network to produce one million drones annually, challenging market leaders and securing allied defense supply chains.

Tevogen's Dr. Ryan Saadi donates over $88,000 in company stock to a UN-recognized charity, bolstering educational programs for underserved children.

Fourth-generation farmer John Melo brings large-scale operational expertise to the Dairy Council, poised to shape California's dairy sustainability and health initiatives.

Chile's state oil firm, ENAP, sees massive investor demand for its debt buyback, a move that strengthens its balance sheet for a major energy transition.

Mirum raises over a quarter-billion dollars to acquire Bluejay Therapeutics, targeting a high-potential liver disease drug and signaling major growth.

A landmark executive order to reschedule cannabis and create a Medicare CBD program could unleash a $30B market and redefine the economics of the industry.

In a landmark deal, BioMarin acquires Amicus Therapeutics, gaining high-growth drugs and reshaping the landscape for patients with rare genetic disorders.

Loyola Marymount University is expanding its EV charging with ChargePoint's AI platform and maintenance service, creating a reliable network for its community.

Aduro Clean Technologies raises $20M for a key plant, navigating market jitters to fund its game-changing chemical recycling technology.

A strategic partnership aims to merge respiratory rentals with innovative hygiene products, promising better compliance and comfort for millions of CPAP users.